[A critical discussion on the current status of drug treatment of brain aging].
Marino
A
A
Schettini
G
G
D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects*; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use; D003704:Dementia / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D018377:Neurotransmitter Agents / Q000494:pharmacology / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D013004:Somatostatin / Q000494:pharmacology / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use; D014667:Vasopressins / Q000494:pharmacology / Q000627:therapeutic use
D000925:Anticoagulants; D000975:Antioxidants; D002121:Calcium Channel Blockers; D018377:Neurotransmitter Agents; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D014667:Vasopressins; D013004:Somatostatin
Critica sullo stato attuale dei farmaci della senescenza cerebrale.